Dr. Nathan Painter: Family Medicine

Research Summary: Family Medicine

Dr. Painter is currently involved in researching the impact of pharmacists and pharmacy students to enable seniors who were enrolled in a Part D plan to select a PDP that minimized their out-of-pocket expenditures and whether and to what extent student pharmacists’ interventions reduce out-of-pocket PDP costs for Medicare beneficiaries. Other research areas of focus include measuring the impact of pharmacist interventions in diabetes, hypertension, hyperlipidemia, collaborative care, and safe medication usage in patient populations.
Dr. Painter joined the faculty at the UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences in September 2009 where he will be teaching in the Pharmacy Practice courses and practicing at UCSD Family Medicine Clinics.

Academic Achievements

Education: Completion of pre-pharmacy requirements (1999) Old Dominion University; Pharm.D. (2003) Virginia Commonwealth University (VCU); ASHP Ambulatory Care Residency in Cardiovascular Risk Reduction (2004) Virginia Commonwealth University VCU; Certified in Immunization Delivery (2001); Certified Diabetes Educator (2007); Certified in Pharmaceutical Care for Patients with Diabetes (2007).

Awards and Honors: Resident Research Project of the Year Award, UCSD Medical Center (2004); ASHP Research and Education Foundation Pain Management Traineeship (2008); Nominated and awarded for Marquis Who’s Who in America (2009); Selected for the National Center for Leadership in Academic Medicine (NCLAM) (2009).

Leadership Experience: President, Southern California College of Clinical Pharmacy; First ambulatory care pharmacist at Loma Linda University to establish a collaborative practice agreement with physicians with prescribing authority.

Teaching

• Pharmacy Practice (SPPS 201, 202, 203).

Key Contributions to Pharmaceutical Sciences

• Established role of ambulatory care/family medicine pharmacist.
• Effective use of medications in family medicine patients.
• Development and expansion of family medicine clerkships for pharmacy students.

Selected Recent Publications

Painter et al. (2006) New and Standard Treatment Options for Type 2 Diabetes. Diabetic Microvascular Complications Today. 3:40-47.

Painter NA. (2007). New Treatment Options for Persons with Diabetes. Drug Benefit Trends. 19 (Supplement B): 10-14.

Painter, NA. (2007). Insulin and Drugs Used for the Treatment of Diabetes: Clinical Significance. In Foye's Principles of Medicinal Chemistry. 6th edition.
Lippincott Williams & Wilkins, Baltimore.

Painter et al. (2008). Management of Children with Diabetes in the School Setting. The Diabetes Educator. 34:439-443.

Potential Collaborative Programs with the Pharmaceutical Industry

• Evaluation of Medicare Part D cost savings.
• Developing guidelines for the use of diabetes and cardiovascular medications.
• Developing educational workshops for diabetes and cardiovascular disease patients.
• Assessing impact of collaborative care on patient outcomes.